The Company anticipates full-year 2025 total revenue of $732M, reflecting growth of approximately 20% compared to the full-year 2024. This includes surgical revenue of approximately $657M and approximately $75M of EOS revenue. The Company also expects adjusted EBITDA of approximately $75M, which will contribute to positive free cash flow for the full-year 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC: